Overview
Flibanserin is included in DrugStatusIndex as part of a structured FDA-status reference covering medications, compounds, peptides, and drug-name search terms.
Flibanserin is FDA approved by prescription for acquired, generalized hypoactive sexual desire disorder in premenopausal women under its labeling.
Flibanserin is included in DrugStatusIndex as part of a structured FDA-status reference covering medications, compounds, peptides, and drug-name search terms.
Current working status: FDA Approved. FDA-approved prescription medication with specific indication and safety requirements.
Available through licensed pharmacies when prescribed; safety labeling applies.
FDA-approved product; compounding is generally not needed when approved product is available.
Use DrugStatusIndex to review FDA approval status, prescription classification, and regulatory context.